Inhibition of NO-mediated responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450

British Journal of Pharmacology

Volumn 118, Issue 1, 1996, Pages 57-62

  Li, C G ^a   Rand, M J ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

7 ethoxyresorufin; Anococcygeus muscle; Cytochrome P450; Endothelium derived relaxing factor (EDRF); Nitrergic nerves; Nitric oxide; Nitric oxide synthase

Indexed keywords

8 BROMO CYCLIC GMP; 8-BROMOCYCLIC GMP; ACETYLCHOLINE; ARGININE; CATALASE; CYCLIC GMP; CYTOCHROME P450; DRUG DERIVATIVE; ENZYME INHIBITOR; ETHOXYRESORUFIN; NITRIC OXIDE; OXAZINE DERIVATIVE; RESORUFIN; SUPEROXIDE DISMUTASE; TROLEANDOMYCIN; VASODILATOR AGENT; 8 BROMO CYCLIC AMP; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM; PAPAVERINE;

ANIMAL; ARTICLE; BINDING COMPETITION; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; INNERVATION; MALE; MUSCLE RELAXATION; PHYSIOLOGY; RABBIT; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; ANIMAL TISSUE; ANOCOCCYGEUS MUSCLE; CONTROLLED STUDY; ENZYME SUBSTRATE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ARGININE; BINDING, COMPETITIVE; CATALASE; CYCLIC GMP; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OXAZINES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TROLEANDOMYCIN; VASODILATOR AGENTS;

EID: 0029666091     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15366.x     Document Type: Article

References (42)

1. BARBIER, A.J. & LEFEBVRE, R.A. (1992). Effect of LY 83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur. J. Pharmacol., 219, 331-334.
2. BATES, J, BAKER, M.T., GUERRA, R. & HARRISON, D.G. (1991). Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol., 42, S157-S165.
3. 450 substrate, 7-ethoxyresorufin. Can. J. Physiol. Pharmacol., 70, 1297-1303.
4. BOECKXSTAENS, G.E., DE MAN, J.G., DE WINTER, B.J., HERMAN, A.G. & PELCKMANS, P.A. (1994). Pharmacological similarity between nitric oxide and the nitrergic neurotransmitter in the canine ileocolonic junction. Eur. J. Pharmacol., 264, 85-89.
5. 2 to nitric oxide and citrulline. Biochem. Biophys. Res. Commun., 187, 880-885.
6. BREDT, D.S., HWANG, P.M., GLATT, C.E., LOWENSTEIN, C., REED, R.R. & SNYDER, S.H. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351, 714-718.
7. DI IULIO, J.L., GUDE, N.M., LI, C.G., RAND, M.J. & KING, R.G. (1993). Cytochrome P450 inhibitor 7-ethoxyresorufin inhibits human placental nitric oxide synthase. Clin. Exp. Pharmacol. Physiol., Suppl. 1, 20.
8. 450 reductase. Arch. Biochem. Biophys., 268, 605-616.
9. 450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol., 107, 722-755.
10. GARVEY, E.P., TUTTLE, J.V., COVINGTON, K., MERRILL, B.M., WOOD, E.R., BAYLIS, S.A. & CHARLES, I.G. (1994). Purification and characterisation of the constitutive nitric oxide synthase from human placenta. Arch. Biochem. Biophys., 311, 235-241.
11. GILLESPIE, J.S. (1972). The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol., 45, 404-416.
12. GUDE, N.M., DI IULIO, J.D., BRENNECKE, S.P. & KING, R.G. (1994). Human placental villous nitric oxide synthase activity. Pharmacol. Commun., 4, 163-171.
13. HOBBS, A.J., TUCKER, J.F. & GIBSON, A. (1991). Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non-vascular smooth muscle: role of superoxide anions. Br. J. Pharmacol., 104, 645-650.
14. 450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am. J. Physiol., 266, H1879-H1885.
15. KENKARE, S.R. & BENET, L.Z. (1993). Effect of ethacrynic acid, a glutathione-S-transferase inhibitor, on nitroglycerin-mediated cGMP elevation and vasorelaxation of rabbit aortic strips. Biochem. Pharmacol., 46, 279-284.
16. KLATT, P., SCHMIDT, K. & MAYER, B. (1992). Brain nitric oxide synthase is a haemoprotein. Biochem. J., 288, 15-17.
17. KOWALUK, E.A., SETH, P. & FUNG, H.-L. (1992). Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther., 262, 916-922.
18. LI, C.G. & RAND, M.J. (1989). Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin. Exp. Pharmacol. Physiol., 16, 933-938.
19. 450 inhibitor 7-ER. Clin. Exp. Pharmacol. Physiol., Suppl. 1, 43.
20. LIU, Z., BRIEN, J.F., MARK, G.S., MCLAUGHLIN, B.E. & NAKATSU, K. (1992). Carbon monoxide does not inhibit glyceryl trinitrate biotransformation by or relaxation of aorta. Eur. J. Pharmacol., 211, 129-132.
21. MARTIN, W., MCALLISTER, K.M.H. & PAISLEY, K. (1994). NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamate. Neuropharmacology, 33, 1293-1301.
22. 450. Biochem. Pharmacol., 45, 268-270.
23. MONCADA, S., PALMER, M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
24. 450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol., 12, 1-51.
25. OSAWA, Y. & DAVILA, J.C. (1993). Phencyclidine, a psychotomimetic agent and drug of abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem. Biophys. Res. Commun., 194, 1435-1439.
26. 450-dependent vasodilator responses to arachidonic acid in the isolated perfused kidney of the rat. Circ. Res., 68, 958-965.
27. 450 inhibitors. J. Pharmacol. Exp. Ther., 268, 262-269.
28. RAJANAYAGAM, M.A., LI, C.G. & RAND, M.J. (1993). Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br. J. Pharmacol., 108, 3-5.
29. 450 inhibitor 7-ER on relaxations to nitrergic nerve stimulation and exogenous nitric oxide. Clin. Exp. Pharmacol. Physiol., Suppl. 1, 59.
30. RAND, M.J. & LI, C.G. (1993b). The inhibition of nitric oxide-mediated relaxations in rat aorta and anococcygeus muscle by diphenylene iodonium. Clin. Exp. Pharmacol. Physiol., 20, 141-148.
31. RAND, M.J. & LI, C.G. (1995a). Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission. Annu. Rev. Physiol., 57, 659-682.
32. RAND, M.J. & LI, C.G. (1995b). Nitric oxide in the autonomic and enteric nervous systems. In Nitric Oxide in the Nervous System. ed. Vincent, S.R. pp. 227-279, London: Academic Press.
33. 450 inhibitors on nitric oxide synthase-dependent responses in rat aorta and anococcygeus muscle. Br. J. Pharmacol., (Strathclyde Meeting in press). 116, 318P.
34. 450S. Biochem. Biophys. Res. Commun., 192, 53-60.
35. 450 mediates bioactivation of organic nitrate. J. Pharmacol. Exp. Ther., 262, 298-302.
36. STADLER, J., TROCKFELD, J., SCHMALIX, W.A. BRILL, T. SIEWERT, J.R., GREIM, H. & DOEHMER, J. (1994). Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 91, 3559-3563.
37. 450 1A1 and 1A2. J. Pharmacol. Exp. Ther., 265, 401-407.
38. WHITE, K.A. & MARLETTA, M.A. (1992). Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry, 31, 6627-6631.
39. 450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys., 300, 115-123.
40. WOLFF, D.J., DATTO, G.A. & SAMATOVICZ, R.A. (1993). The dual mode of inhibition of calmodulin-dependent nitric oxide synthase by antifungal imidazole agents. J. Biol. Chem., 268, 9430-9436.
41. YEATES, R., SCHMID, M. & LEITOLD, M. (1989). Antagonism of glycerol trinitrate activity by an inhibitor of glutathione S-transferase. Biochem. Pharmacol., 38, 1749-1753.
42. ZEMBOWICZ, A., HATCHETT, R.J., RADZISZEWSKI, W. & GRYGLEWSKI, J. (1993). Inhibition of endothelial nitric oxide synthase by ebselen, prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. J. Pharmacol. Exp. Ther., 267, 1112-1118.